title: Evaluation of the efficacy of sodium valproate in convulsive status epilepticus following to ıschemic stroke.
abstract: OBJECTIVE
  Convulsive status epilepticus (CSE) is very rarely observed after ischaemic stroke. Sodium valproate (SV) is one of the agents used in the treatment of CSE, but its role still controversial, and its degree of efficacy in treating CSE that develops following stroke is unclear.
  
  
  METHODS
  We evaluated 19 patients who were treated with intravenous (IV) SV (20 mg/kg, 2 mg/kg/h-12h) after diazepam. Patients' modified Rankin scores (mRS), SE types, and changes in biochemical parameters after treatment were assessed.
  
  
  RESULTS
  CSE was successfully treated in 12 (63.15%) patients. Side effects such as hypotension and allergic reactions were observed in two patients. Refractory SE development was observed in 5 (29.4%) patients with high mRS (˃ 3). No significant deterioration in patients' laboratory evaluations, conducted before and after status, was observed.
  
  
  CONCLUSIONS
  SV may be safe and effective in the treatment of CSE observed after ischaemic stroke, especially in patients with low mRS.
authors.affiliation: Dicle University Neurology, Diyarbakır, Turkey.
authors.forename: Hasan Hüseyin
authors.initials: HH
authors.lastname: Özdemir
authors.affiliation: Fırat University Neurology, Elazığ, Turkey.
authors.forename: Bülent
authors.initials: B
authors.lastname: Müngen
authors.affiliation: Fırat University Pharmacology Department, Elazığ, Turkey.
authors.forename: Selçuk
authors.initials: S
authors.lastname: İlhan
mesh_terms: D061605:Administration, Intravenous; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000927:Anticonvulsants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D012640:Seizures / Q000188:drug therapy* / Q000209:etiology; D012737:Sex Factors; D013226:Status Epilepticus / Q000188:drug therapy* / Q000209:etiology; D020521:Stroke / Q000150:complications*; D013997:Time Factors; D016896:Treatment Outcome; D014635:Valproic Acid / Q000627:therapeutic use*
chemical_list: D000927:Anticonvulsants; D014635:Valproic Acid